Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2867 USD | +12.39% | -7.37% | +89.37% |
May. 14 | Earnings Flash (JAGX) JAGUAR HEALTH Reports Q1 Revenue $2.4M, vs. Street Est of $3M | MT |
May. 14 | Transcript : Jaguar Health, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Financials (USD)
Sales 2024 * | 15.11M | Sales 2025 * | 22.66M | Capitalization | 70.46M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -21M | EV / Sales 2024 * | 4.66 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.11 x |
P/E ratio 2024 * |
-3.19
x | P/E ratio 2025 * |
-4.1
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.78% |
Latest transcript on Jaguar Health, Inc.
1 day | +12.39% | ||
1 week | +7.22% | ||
Current month | +33.54% | ||
1 month | +141.33% | ||
3 months | +249.63% | ||
6 months | -24.89% | ||
Current year | +89.37% |
Managers | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 13-06-05 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 19-04-30 |
Chief Tech/Sci/R&D Officer | 60 | 17-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 13-06-05 |
James Bochnowski
CHM | Chairman | 80 | 14-01-31 |
John Micek
BRD | Director/Board Member | 71 | 16-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 0.2867 | +12.39% | 30,959,883 |
24-05-15 | 0.2551 | -7.20% | 25,164,148 |
24-05-14 | 0.2749 | -5.30% | 63,969,137 |
24-05-13 | 0.2903 | -0.62% | 24,976,434 |
24-05-10 | 0.2921 | -5.62% | 27,975,022 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+89.37% | 70.46M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- JAGX Stock